LMNL Annual Accounts Receivable
$183.50 K
+$3900.00+2.17%
31 December 2022
Summary:
As of February 5, 2025, LMNL annual accounts receivable is $183.50 thousand, with the most recent change of +$3900.00 (+2.17%) on December 31, 2022. During the last 3 years, it has risen by +$149.80 thousand (+444.51%).LMNL Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL Quarterly Accounts Receivable
$594.60 K
-$166.90 K-21.92%
30 June 2023
Summary:
As of February 5, 2025, LMNL quarterly accounts receivable is $594.60 thousand, with the most recent change of -$166.90 thousand (-21.92%) on June 30, 2023. Over the past year, it has dropped by -$554.00 thousand (-48.23%).LMNL Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.2% | -48.2% |
| 3 y3 years | +444.5% | +116.5% |
| 5 y5 years | -87.2% | -58.8% |
LMNL Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -97.7% | -96.3% |
Liminal BioSciences Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $594.60 K(-21.9%) |
| Mar 2023 | - | $761.50 K(+315.0%) |
| Dec 2022 | $183.50 K(+2.2%) | $183.50 K(-83.2%) |
| Sept 2022 | - | $1.10 M(-4.6%) |
| June 2022 | - | $1.15 M(+79.5%) |
| Mar 2022 | - | $640.00 K(+256.3%) |
| Dec 2021 | $179.60 K(-75.7%) | $179.60 K(-81.0%) |
| Sept 2021 | - | $947.10 K(-28.8%) |
| June 2021 | - | $1.33 M(-69.7%) |
| Mar 2021 | - | $4.39 M(+493.6%) |
| Dec 2020 | $739.50 K(+2094.4%) | $739.50 K(+400.0%) |
| Sept 2020 | - | $147.90 K(-46.1%) |
| June 2020 | - | $274.60 K(-61.6%) |
| Mar 2020 | - | $715.00 K(+2021.7%) |
| Dec 2019 | $33.70 K(-99.3%) | $33.70 K(-98.0%) |
| Sept 2019 | - | $1.68 M(-59.6%) |
| June 2019 | - | $4.14 M(-10.2%) |
| Mar 2019 | - | $4.61 M(-10.9%) |
| Dec 2018 | $5.18 M(+262.5%) | $5.18 M(+689.6%) |
| Sept 2018 | - | $655.60 K(-54.5%) |
| June 2018 | - | $1.44 M(-14.9%) |
| Mar 2018 | - | $1.69 M(+18.6%) |
| Dec 2017 | $1.43 M(-47.2%) | $1.43 M(-91.0%) |
| Sept 2017 | - | $15.90 M(+2020.5%) |
| June 2017 | - | $749.70 K(-66.1%) |
| Mar 2017 | - | $2.21 M(-18.2%) |
| Dec 2016 | $2.71 M(-11.9%) | $2.71 M(+4.8%) |
| Sept 2016 | - | $2.58 M(+9.9%) |
| June 2016 | - | $2.35 M(-26.8%) |
| Mar 2016 | - | $3.21 M(+4.5%) |
| Dec 2015 | $3.07 M(-57.8%) | $3.07 M(+97.0%) |
| Sept 2015 | - | $1.56 M(+7.9%) |
| June 2015 | - | $1.45 M(-10.5%) |
| Mar 2015 | - | $1.62 M(-77.8%) |
| Dec 2014 | $7.28 M(-9.0%) | $7.28 M(+380.4%) |
| Sept 2014 | - | $1.51 M(-69.0%) |
| June 2014 | - | $4.89 M(-49.3%) |
| Mar 2014 | - | $9.65 M(+20.6%) |
| Dec 2013 | $8.00 M(+203.6%) | $8.00 M(+57.3%) |
| Sept 2013 | - | $5.09 M(+60.6%) |
| June 2013 | - | $3.17 M(+47.5%) |
| Mar 2013 | - | $2.15 M(-18.5%) |
| Dec 2012 | $2.64 M(+1199.6%) | $2.64 M(-55.9%) |
| Sept 2012 | - | $5.98 M(+40.5%) |
| June 2012 | - | $4.25 M(+123.4%) |
| Mar 2012 | - | $1.90 M(+838.8%) |
| Dec 2011 | $202.80 K(-88.7%) | $202.80 K(-89.4%) |
| Sept 2011 | - | $1.91 M(-16.4%) |
| June 2011 | - | $2.29 M(+48.5%) |
| Mar 2011 | - | $1.54 M(-13.9%) |
| Dec 2010 | $1.79 M | $1.79 M(-2.4%) |
| Sept 2010 | - | $1.83 M(-2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $1.89 M(-48.1%) |
| Mar 2010 | - | $3.64 M(+46.8%) |
| Dec 2009 | $2.48 M(-30.8%) | $2.48 M(+65.0%) |
| Sept 2009 | - | $1.50 M(-33.6%) |
| June 2009 | - | $2.26 M(-33.0%) |
| Mar 2009 | - | $3.38 M(-5.7%) |
| Dec 2008 | $3.58 M(+6.8%) | $3.58 M(+16.4%) |
| Sept 2008 | - | $3.08 M(+0.7%) |
| June 2008 | - | $3.06 M(+2.7%) |
| Mar 2008 | - | $2.97 M(-11.3%) |
| Dec 2007 | $3.36 M(+70.3%) | $3.36 M(+30.3%) |
| Sept 2007 | - | $2.58 M(-50.8%) |
| June 2007 | - | $5.24 M(+135.0%) |
| Mar 2007 | - | $2.23 M(+13.1%) |
| Dec 2006 | $1.97 M(-21.4%) | $1.97 M(+46.5%) |
| Sept 2006 | - | $1.35 M(+115.2%) |
| June 2006 | - | $625.20 K(+55.1%) |
| Mar 2006 | - | $403.20 K(-83.9%) |
| Dec 2005 | $2.51 M(+7.8%) | $2.51 M(+36.0%) |
| Sept 2005 | - | $1.84 M(-22.9%) |
| June 2005 | - | $2.39 M(-39.5%) |
| Mar 2005 | - | $3.95 M(+69.9%) |
| Dec 2004 | $2.33 M(+341.5%) | $2.33 M(+168.8%) |
| Sept 2004 | - | $865.60 K(+6.7%) |
| June 2004 | - | $811.30 K(+27.2%) |
| Mar 2004 | - | $638.00 K(+21.1%) |
| Dec 2003 | $527.00 K(-52.2%) | $527.00 K(-21.8%) |
| Sept 2003 | - | $674.10 K(-4.5%) |
| June 2003 | - | $705.80 K(+10.7%) |
| Mar 2003 | - | $637.80 K(-42.2%) |
| Dec 2002 | $1.10 M(+90.7%) | $1.10 M(+34.3%) |
| Sept 2002 | - | $821.60 K(-46.4%) |
| June 2002 | - | $1.53 M(+83.9%) |
| Mar 2002 | - | $833.90 K(+44.1%) |
| Dec 2001 | $578.60 K(+65.7%) | $578.60 K(-31.0%) |
| Sept 2001 | - | $838.70 K(+132.9%) |
| June 2001 | - | $360.10 K(+18.7%) |
| Mar 2001 | - | $303.40 K(-13.1%) |
| Dec 2000 | $349.20 K(+154.0%) | $349.20 K(-69.5%) |
| Sept 2000 | - | $1.14 M(+182.4%) |
| June 2000 | - | $405.00 K(-1.9%) |
| Mar 2000 | - | $413.00 K(+200.4%) |
| Dec 1999 | $137.50 K(-97.4%) | $137.50 K(+0.9%) |
| Sept 1999 | - | $136.30 K(-98.4%) |
| June 1999 | - | $8.46 M(+48.4%) |
| Mar 1999 | - | $5.70 M(+6.3%) |
| Dec 1998 | $5.36 M(+573.3%) | $5.36 M(+226.9%) |
| Sept 1998 | - | $1.64 M(+71.8%) |
| June 1998 | - | $954.70 K(+23.6%) |
| Mar 1998 | - | $772.70 K(+0.7%) |
| Dec 1997 | - | $767.50 K |
| Sept 1997 | $796.30 K | - |
FAQ
- What is Liminal BioSciences annual accounts receivable?
- What is the all time high annual accounts receivable for Liminal BioSciences?
- What is Liminal BioSciences annual accounts receivable year-on-year change?
- What is Liminal BioSciences quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Liminal BioSciences?
- What is Liminal BioSciences quarterly accounts receivable year-on-year change?
What is Liminal BioSciences annual accounts receivable?
The current annual accounts receivable of LMNL is $183.50 K
What is the all time high annual accounts receivable for Liminal BioSciences?
Liminal BioSciences all-time high annual accounts receivable is $8.00 M
What is Liminal BioSciences annual accounts receivable year-on-year change?
Over the past year, LMNL annual accounts receivable has changed by +$3900.00 (+2.17%)
What is Liminal BioSciences quarterly accounts receivable?
The current quarterly accounts receivable of LMNL is $594.60 K
What is the all time high quarterly accounts receivable for Liminal BioSciences?
Liminal BioSciences all-time high quarterly accounts receivable is $15.90 M
What is Liminal BioSciences quarterly accounts receivable year-on-year change?
Over the past year, LMNL quarterly accounts receivable has changed by -$554.00 K (-48.23%)